Pharma & Biotech

Australian biotechnology firm Immuron has initiated an unusually proactive communication strategy as it approaches two critical clinical milestones. The developer...

Pulmatrix Inc. is executing a profound strategic transformation, marked by its pending merger with Cullgen and the complete divestiture of...

Krystal Biotech is implementing a significant strategic pivot in response to recent regulatory developments at the U.S. Food and Drug...

Simulations Plus, a specialized software provider, faces a severe crisis of investor confidence. Multiple law firms have initiated investigations into...

Despite a modest pullback to close the week, market experts remain overwhelmingly optimistic about Nkarta Inc. The biotech firm’s shares...